Here, we demonstrated that restoring CDS1 expression in NPC cells significantly increases nuclear NF-κB(p65) levels, leading to upregulation of downstream targets such as inflammatory cytokines IL-6, IL-8, and others. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.